^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ClarityDX Prostate®

    Company:
    Nanostics
    Type:
    CE Marked

    Details

    Evidence
    News
    ClarityDX Prostate® is designed to accurately predict the presence of clinically significant prostate cancer and with the guidance of a physician can be used to inform the decision to biopsy. It can be used to monitor patients on active surveillance to detect the progression to clinically significant prostate cancer and inform the decision to biopsy.
    Cancer:
    Prostate Cancer
    Method:
    Liquid biopsy
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    08/23/22
    PC
    -
    CE